|
|
|
Insider
Information: |
Maduck Sean |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
85,222 |
|
Indirect Shares
|
20,000 |
|
|
Direct
Value |
$2,345,309 |
|
|
Indirect Value
|
$550,400 |
|
|
Total
Shares |
105,222 |
|
|
Total
Value |
$2,895,709 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-73.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Corcept Therapeutics Inc |
CORT |
|
2024-05-13 |
85,222 |
2024-05-13 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-09-01 |
4 |
A |
$0.00 |
$23,954 |
D/D |
1,844 |
56,462 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-03-01 |
4 |
A |
$0.00 |
$28,996 |
D/D |
2,920 |
59,382 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-06-01 |
4 |
A |
$0.00 |
$38,084 |
D/D |
3,316 |
62,698 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-09-01 |
4 |
A |
$0.00 |
$15,094 |
D/D |
912 |
73,610 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-12-01 |
4 |
A |
$0.00 |
$15,115 |
D/D |
1,164 |
74,455 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-03-01 |
4 |
A |
$0.00 |
$15,302 |
D/D |
1,272 |
75,222 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-07-07 |
4 |
AS |
$22.19 |
$554,693 |
D/D |
(25,000) |
30,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-08-03 |
4 |
AS |
$21.18 |
$529,420 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-09-01 |
4 |
AS |
$21.40 |
$534,930 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-10-01 |
4 |
AS |
$20.00 |
$487,375 |
D/D |
(24,363) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-10-05 |
4 |
AS |
$20.00 |
$12,740 |
D/D |
(637) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-07-18 |
4 |
AS |
$27.37 |
$684,250 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-08-09 |
4 |
AS |
$28.70 |
$5,740 |
D/D |
(200) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-09-01 |
4 |
AS |
$25.84 |
$646,000 |
D/D |
(25,000) |
54,618 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-10-03 |
4 |
AS |
$25.64 |
$641,000 |
D/D |
(25,000) |
56,462 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-11-10 |
4 |
AS |
$25.57 |
$639,250 |
D/D |
(25,000) |
56,462 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-12-01 |
4 |
AS |
$25.28 |
$15,800 |
D/D |
(625) |
56,462 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-09-19 |
4 |
AS |
$32.48 |
$812,000 |
D/D |
(25,000) |
73,610 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-02 |
4 |
AS |
$27.24 |
$82,577 |
D/D |
(3,031) |
73,610 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-06 |
4 |
AS |
$27.24 |
$95,286 |
D/D |
(3,498) |
73,610 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-10 |
4 |
AS |
$27.29 |
$504,038 |
D/D |
(18,471) |
73,291 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-12-01 |
4 |
AS |
$25.56 |
$639,048 |
D/D |
(25,000) |
73,291 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-02-15 |
4 |
AS |
$25.00 |
$119,000 |
D/D |
(4,760) |
74,455 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-02-16 |
4 |
AS |
$25.97 |
$702,905 |
D/D |
(27,068) |
74,455 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-03-18 |
4 |
AS |
$25.00 |
$430,475 |
D/D |
(17,219) |
75,222 |
0 |
% |
|
64 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|